Could novel immune cell therapy combat hepatitis B infections?
Chronic infection with the hepatitis B virus (HBV) causes progressive liver problems, and eradication of the virus remains a formidable challenge.
Apr 10, 2024
0
0
Chronic infection with the hepatitis B virus (HBV) causes progressive liver problems, and eradication of the virus remains a formidable challenge.
Apr 10, 2024
0
0
A 300-mg dose of bepirovirsen per week for 24 weeks results in sustained hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA loss in 9–10% of patients with chronic HBV infection, according to a study published ...
Nov 14, 2022
0
27
Worldwide, 880,000 people die each year as a result of infection with the hepatitis B virus (HBV). Antiviral drugs that can suppress replication of the virus are available. However, these must be taken for decades, as there ...
Jul 28, 2022
0
3
Viral hepatitis is a serious health condition that affects the liver. While hepatitis B and C viruses are commonly targeted by public health measures aiming to reduce the disease burden, there is another, less commonly known ...
Jun 16, 2022
0
8
Scientists at UCL have significantly boosted the effectiveness of a therapeutic vaccine designed to control chronic hepatitis B (HBV) infection, after uncovering and thwarting 'the enemy within'.
Apr 13, 2022
0
62
Infections in humans caused by the hepatitis B virus (HBV) represent a major public health problem. Despite the availability of effective protective vaccines, more than 250 million individuals worldwide are chronically infected ...
Aug 13, 2020
0
4
University of Liverpool researchers have published new estimates of the global burden of hepatitis D, and are calling for more efforts to tackle the 'forgotten' virus.
Apr 30, 2020
0
0
Researchers at Princeton University have identified a set of human proteins that the hepatitis B virus (HBV) uses to establish itself permanently inside liver cells. The study, published in the journal Nature Microbiology, ...
Mar 9, 2020
0
83
Human apolipoprotein E (apoE) promotes hepatitis B virus (HBV) infection and production, according to a study published Aug 8 in the open-access journal PLOS Pathogens by Luhua Qiao and Guangxiang (George) Luo of the University ...
Aug 8, 2019
0
0
New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao ...
Apr 18, 2019
0
62